AOD Health
AOD Health
Episode 3: Dr Christopher Jones, PharmD, DrPH on telehealth and opioid use disorder and overdose treatment during COVID-19
Episode 3: Dr Christopher Jones, PharmD, DrPH on telehealth and opioid use disorder and overdose treatment during COVID-19
Episode 3: Dr Christopher Jones, PharmD, DrPH on telehealth and opioid use disorder and overdose treatment during COVID-19
Wednesday 28th June 2023
Dr. Christopher M. Jones discusses telehealth's role in opioid use disorder treatment during COVID-19, focusing on access disparities and policy impacts.
32 minutes
Informative
Empowering
Thought-provoking
Supportive
Transformative
About this podcast
Author:
AOD Health
Overview:
Categories:
Innovative Treatments & Recovery Paths
Sobriety Toolkit
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
6 (View all)
Do you want to link to this podcast?
Get the buttons here!Telehealth and Opioid Use Disorder: Insights from Dr. Christopher M. Jones
Episode Overview
- The study evaluates the impact of telehealth services and policy changes for opioid use disorder (OUD) during the COVID-19 pandemic
- Dr. Jones discusses disparities in access to OUD telehealth services, emphasizing the importance of equitable healthcare delivery
- Insights into proposed DEA rule changes and impactful research questions that drive policy decisions
- The significance of OUD-related telehealth services for retention in treatment and association with medically treated overdose among Medicare beneficiaries
- Dr. Jones addresses the integration of telehealth into in-person care and the pursuit of equitable healthcare delivery
Telehealth services for OUD are an important tool in the toolbox. How do we integrate that into in-person care and other services? And how do we also continue to advance telehealth in an equitable way? - Dr. Christopher M. Jones
What happens when telehealth meets the pressing issue of opioid use disorder? In this episode of 'Behind the Evidence', Dr. Christopher M. Jones, a leading expert from the CDC, shares his findings on how telehealth services have shaped opioid use disorder (OUD) treatment during the COVID-19 pandemic. Hosted by Dr. Honora L. Englander and Dr. Marc R. Larochelle, this conversation digs into the nitty-gritty of Dr. Jones's recent study published in JAMA Psychiatry.
They explore the utilization of telehealth for OUD, retention rates in treatment, and the crucial link to medically treated overdoses among Medicare beneficiaries. One of the standout points is the stark disparities in access to telehealth services for OUD, shedding light on the ongoing struggle for equitable healthcare delivery. Dr. Jones doesn't shy away from discussing the proposed DEA rule changes and their potential impact on future policies.
This episode is a must-listen for anyone interested in the intersection of technology and addiction treatment, offering a deep dive into the challenges and opportunities presented by telehealth in this critical field.